von Willebrand Factor in Pregnancy (VIP): A multicenter study of WILATE use in von Willebrand Disease for childbirth
Latest Information Update: 12 Jul 2021
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- Acronyms VIP
- Sponsors Octapharma
- 05 Jul 2021 According to an Octapharma media release, data will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress 2021.
- 10 Oct 2019 New trial record
- 04 Oct 2019 According to an Octapharma media release, this trial will be featured in a poster presentation at the 71st Bleeding Disorders Conference.